Ann Arbor, MI, United States of America

Barbara McKenna


Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Barbara McKenna: Innovator in Multimodal Spectroscopy and Liver Disease Treatment

Introduction: Barbara McKenna is a distinguished inventor based in Ann Arbor, MI, recognized for her innovative contributions to the fields of spectroscopy and medical treatments. With a total of four patents to her name, McKenna has made significant strides in understanding and treating various biological conditions.

Latest Patents: Among her latest patents are two notable inventions. The first is a patent for "Multimodal Spectroscopic Systems and Methods for Classifying Biological Tissue." This invention involves the development of multimodal optical spectroscopy systems designed to obtain spectroscopic response data from biological tissues. The systems produce a spectroscopic event either ex vivo or in vivo and allow for the comparison of response data with a model that correlates the measured data to the most probable attributes of the tissue, aiding in its classification.

The second patent addresses "Method of Treating Fatty Liver Diseases and Conditions in Non-Lipodystrophic Subjects." This groundbreaking invention focuses on the use of leptin in treating leptin-responsive diseases in non-lipodystrophic subjects. Specifically, it provides methods for treating nonalcoholic steatohepatitis (NASH), alcoholic fatty liver disease (AFLD), and nonalcoholic fatty liver disease (NAFLD) in individuals suffering from relative leptin deficiency, thus offering hope for effective treatment options.

Career Highlights: Barbara McKenna is affiliated with the University of Michigan, where she continues to conduct impactful research and drive innovation. Her work exemplifies the integration of engineering and biology, pushing the boundaries of what is possible in tissue classification and disease treatment.

Collaborations: Throughout her career, McKenna has collaborated with esteemed colleagues such as Mary-Ann Mycek and Malavika Chandra. These partnerships have enriched her research endeavors and contributed to the advancement of the scientific community's understanding of complex biological systems.

Conclusion: Barbara McKenna's pioneering work in multimodal spectroscopy and treatments for fatty liver diseases illustrates her commitment to innovation and improving health outcomes. Her contributions not only enhance scientific knowledge but also pave the way for future developments in medical technology and therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…